{"id":"iv-sildenafil","safety":{"commonSideEffects":[{"rate":"16%","effect":"Headache"},{"rate":"10%","effect":"Flushing"},{"rate":"7%","effect":"Dyspepsia"},{"rate":"6%","effect":"Back pain"},{"rate":"5%","effect":"Muscle pain"},{"rate":"5%","effect":"Nasal congestion"},{"rate":"4%","effect":"Dizziness"},{"rate":"4%","effect":"Vision changes"},{"rate":"3%","effect":"Abnormal vision"},{"rate":"3%","effect":"Abnormal dreams"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"PDE5 is an enzyme found in the smooth muscle of the corpus cavernosum of the penis. By inhibiting PDE5, sildenafil increases the levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation and increased blood flow.","oneSentence":"Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that works by increasing blood flow to the penis to treat erectile dysfunction.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:48:59.002Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Erectile dysfunction"}]},"trialDetails":[{"nctId":"NCT03142568","phase":"PHASE2","title":"Safety of Sildenafil in Premature Infants","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-02","conditions":"Bronchopulmonary Dysplasia","enrollment":109},{"nctId":"NCT06810284","phase":"PHASE2","title":"Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-10","conditions":"Hypoxic-Ischemic Encephalopathy","enrollment":24},{"nctId":"NCT04447989","phase":"PHASE2","title":"Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia","status":"COMPLETED","sponsor":"Christoph Hornik","startDate":"2021-05-27","conditions":"Bronchopulmonary Dysplasia of Newborn","enrollment":125},{"nctId":"NCT00303459","phase":"PHASE4","title":"Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","sponsor":"Actelion","startDate":"2006-05","conditions":"Pulmonary Arterial Hypertension","enrollment":334},{"nctId":"NCT06317805","phase":"PHASE4","title":"Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients","status":"RECRUITING","sponsor":"AOP Orphan Pharmaceuticals AG","startDate":"2023-12-06","conditions":"Pulmonary Arterial Hypertension","enrollment":110},{"nctId":"NCT04058132","phase":"PHASE2","title":"Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military","status":"TERMINATED","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2019-08-09","conditions":"Traumatic Brain Injury","enrollment":1},{"nctId":"NCT01954524","phase":"PHASE1","title":"A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2014-05","conditions":"Cirrhosis","enrollment":2},{"nctId":"NCT01720524","phase":"PHASE3","title":"A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-08-05","conditions":"Pulmonary Hypertension, Familial Persistent, of the Newborn","enrollment":59},{"nctId":"NCT01360671","phase":"PHASE2","title":"IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn","status":"WITHDRAWN","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-03","conditions":"Persistent Pulmonary Hypertension of the Newborn","enrollment":""},{"nctId":"NCT00800592","phase":"PHASE1","title":"Sildenafil IV Bolus Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-10","conditions":"Hypertension, Pulmonary","enrollment":12},{"nctId":"NCT01069861","phase":"PHASE2","title":"Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-12","conditions":"PPHN, Persistent Pulmonary Hypertension of the Newborn, Hypoxic Respiratory Failure","enrollment":4},{"nctId":"NCT00972569","phase":"PHASE1, PHASE2","title":"Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-10","conditions":"Heart Failure, Renal Dysfunction","enrollment":60},{"nctId":"NCT01375699","phase":"PHASE1","title":"Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2011-08-11","conditions":"Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer","enrollment":26},{"nctId":"NCT03259516","phase":"PHASE1, PHASE2","title":"Nivolumab With Chemotherapy in Refractory MDS","status":"TERMINATED","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2017-05-25","conditions":"Myelodysplastic Syndromes","enrollment":2},{"nctId":"NCT01670136","phase":"PHASE1","title":"Pharmacokinetics of Sildenafil in Premature Infants","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2013-02","conditions":"Persistent Pulmonary Hypertension of the Newborn","enrollment":34},{"nctId":"NCT02595541","phase":"PHASE1, PHASE2","title":"Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-06","conditions":"Pulmonary Hypertension","enrollment":30},{"nctId":"NCT01800292","phase":"PHASE4","title":"Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2013-02","conditions":"Hypertension, Pulmonary Artery, Ventricular Dysfunction, Left","enrollment":9},{"nctId":"NCT00461565","phase":"PHASE4","title":"FDA Phase IV - Commitment - Retinal Function Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-02","conditions":"Safety","enrollment":63},{"nctId":"NCT01637675","phase":"PHASE2, PHASE3","title":"Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2013-05","conditions":"Pulmonary Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Diseases","enrollment":90},{"nctId":"NCT01055405","phase":"PHASE4","title":"Study of Sildenafil Effects in Combination With Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Associated Pulmonary Hypertension","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2008-08","conditions":"COPD, Pulmonary Hypertension","enrollment":65}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["revatio"],"phase":"phase_3","status":"active","brandName":"iv sildenafil","genericName":"iv sildenafil","companyName":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","companyId":"pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that works by increasing blood flow to the penis to treat erectile dysfunction. Used for Erectile dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}